title: Future directions for NIH-supported pediatric AIDS research.
abstract: The Office of AIDS Research (OAR) at the National Institutes of Health (NIH) is responsible for the coordination of AIDS research. In June 1999, the OAR, in conjunction with the NIH Institutes and Centers, initiated a review of NIH-sponsored pediatric AIDS research. This article discusses a number of important priorities for future clinical research in NIH-sponsored pediatric AIDS in both developed and developing countries. These have the potential to significantly prevent perinatal transmission, reduce adolescent infections, and impact treatment of pediatric infections.
authors.affiliation: Office of AIDS Research, National Institutes of Health, United States Department of Health and Human Services, Bethesda, Maryland 20892, USA. nathansn@od.nih.gov
authors.forename: N
authors.initials: N
authors.lastname: Nathanson
authors.forename: R W
authors.initials: RW
authors.lastname: Eisinger
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D017954:Africa South of the Sahara / Q000453:epidemiology; D019380:Anti-HIV Agents / Q000627:therapeutic use; D002648:Child; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D015994:Incidence; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D009316:National Institutes of Health (U.S.); D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology / Q000517:prevention & control; D015995:Prevalence; D012109:Research Support as Topic; D014481:United States / Q000453:epidemiology; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D015215:Zidovudine